Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-042784

General Counsel sold 53,389 shares at $2.39 ($127,813)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-05 Sale : show line 1 in the form −53,389 $2.39 $127,813 545,100 D
Open-market sales · 53,389 sh · avg $2.39 · $127,813
Loading xslF345X06/form4.xml…